En
En
Fr
Fr
De
De
It
It
Es
Es
Cn
Cn
16 YEARS OF INTERNATIONAL CLINICAL EXPERIENCE IN TRANSPLANTATION OF HUMAN EMBRYONIC/FETAL STEM CELLS
THE WORLDS LARGEST CLINICAL EXPERIENCE IN EMBRYONIC STEM CELL TRANSPLANTATION FOR VARIOUS DISEASES AND CONDITIONS.

Home
About EmCell
EmCell Therapy
Our Experience
List of Diseases:
Oncology
Diabetes Mellitus
Nervous System
Aging Problems
Immune Deficiency
Endoscopic Treatment of Liver Diseases
Investment Projects
Clinical Trials
Congresses and Conferences
Video and other materials
Mail Center

Publications

15. New method of immune substituting therapy with the use of fetal cells in cases of hiv infection (AIDS)

Smikodoub Alexander, Pilipchak Elena
Cell Therapy Clinic of National Medical University and Embryonic Tissues Center "EmCell"


Immune substituting therapy by means of transplantation of fetal cell suspensions having high contents of stem cells of hemopoiesis was carried out in 38 HIV infected patients, among which one man was a carrier, 8 patients suffered from AIDS-AC, and 29 from AIDS. Average age of patients was 35 years. Transplantations were carried out by intravenous and subcutaneous administration of fetal cell suspensions. All patients easily agreed to transplantations and endured them satisfactorily

Generally, during two weeks after transplantation an improvement was observed in patients: energy increase, 45%; improvement of sleep, 39%;

decrease of ache and pain, 13%; decrease in irritation, 32%; increase of work capability, 18%; decrease offatiguability, 37%; improvement of spirits, 55%.

Considerable and statistically valid improvement of CD3+, CD4+ and CD8+ indi- ces was observed on the 12th day and remained during 2 months. The CD4+/CD8+ ratio increased during the first week; it however decreased later on. We observed maintenance of the increased level of CD3+ and CD4+ during 3 to 8 and even 18 months.

In 17 (77%) patients suffering from astheno-neurotic syndrome, observed were substantial improvement of general state. In patients suffering from paresis and neuropathy, the scope of movements of injured extremities increased.

In 10 patients, pathology of the respiratory system was observed (bronchitis, pneu- monia, pulmonary tuberculosis). 2 weeks after transplantation, against the back- ground of standard therapy, observed in these patients was a decrease of the bron- choobstructive syndrome; in patients suffering from tuberculosis, general state im- proved and decreased the body temperature, patients.


Smikodoub Alexander, Pilipchak Elena NEW METHOD OF IMMUNE SUBSTITUTING THERAPY WITH THE USE OF FETAL CELLS IN CASES OF HIV INFECTION (AIDS) Fourth International Congress of Cell Transplantation Society. Montreux / Switzerland, March 1999. Cell Transplantation, v.8, n.2. 1999, p. 120.



News
2008-09-25
Prof. Alexander I. Smikodub attended European Congress on Anti-Aging and

Prof. Alexander I. Smikodub attended European Congress on Anti-Aging and Aesthetic Medicine held in Dusseldorf, Germany on September 11-14, 2008 as ...
  Other news
 
Publications

25. Application Of Embryonic Cell Suspensions In Patients With Solid Tumors Before Initiation Of Radical Treatment

Smikodub O.
Cell Therapy Clinic of National Medical University and Embryonic Tissues Center EmCell

Patients with solid tumors and complications that made initiations of anti-cancer treatment impossible, were ...
  Other publications
 
Patents

Medicinal preparation based on fetal cell suspension having immune substituting effect for patients with acquired immune ...
   
 
Copyright © 1999-2008 EmCell.com